Greater than 78% of participants on 15 mg achieved 15% weight loss, and 36% achieved 25%
PubMed evidence trail Research sources used to frame this page For Hers vs GoodRx: GLP-1 Program Comparison 2026, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available
Partial ligament tear with significant pain and swelling
Originally developed for managing Type 2 diabetes , these injections have shown significant benefits for people with obesity and other metabolic conditions, offering a new treatment option for those who need help with weight loss and blood sugar control
Last reviewed: June 18, 2026 Last updated: June 18, 2026 Written by: Jay Hastings, CEO of PlexusDx Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations